June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
A longitudinal study of a large single-family-pedigree with autosomal dominant radial drusen.
Author Affiliations & Notes
  • Christopher Nathaniel Roybal
    Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, IA
  • Yasser Elshatory
    Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, IA
  • Douglas J Oppedal
    Department of Ophthalmology, Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Sara E Miller
    Department of Ophthalmology, Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Edwin M Stone
    Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, IA
    Department of Ophthalmology, Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Elliott H Sohn
    Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, IA
    Department of Ophthalmology, Stephen A. Wynn Institute for Vision Research, Iowa City, IA
  • Footnotes
    Commercial Relationships Christopher Roybal, None; Yasser Elshatory, None; Douglas Oppedal, None; Sara Miller, None; Edwin Stone, None; Elliott Sohn, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3831. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Christopher Nathaniel Roybal, Yasser Elshatory, Douglas J Oppedal, Sara E Miller, Edwin M Stone, Elliott H Sohn; A longitudinal study of a large single-family-pedigree with autosomal dominant radial drusen.. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3831.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

To characterize a multi-generational family with autosomal dominant radial drusen (ADRD)/Malattia Leventinese and confirmed fibulin-3/EFEMP1 (R345W) mutations longitudinally.

 
Methods
 

Twenty-eight subjects from a common multi-generational pedigree were ascertained with molecularly confirmed R345W substitutions in fibulin-3. The patients were characterized with spectral domain optical coherence tomography (SD-OCT), fundus autofluorescence and color fundus photography. Images were evaluated for presence of radial drusen, macular pigmentation, atrophy and presence of choroidal neovascular membrane (CNVM).

 
Results
 

Affected family members were segregated into three phenotypes (mild, intermediate, severe) based on visual acuity and fundus findings. Three patients (aged 27, 34, and 48) with confirmed mutations had no fundus findings consistent with the known phenotype. Five had the mild phenotype (mean age 38 years old, range 19-73); median visual acuity was 20/20. Six had the intermediate phenotype (mean age of 66, range 47-78) and median visual acuity was 20/40 with macular pigment and atrophy present in 50% and 75% of patients, respectively. Radial drusen was present in 83% of intermediate patients and 1 had a CNVM (17%). Eleven patients had the severe phenotype (mean age 61, range 38-80) and mean visual acuity was 20/200. All severe patients had radial drusen and macular RPE atrophy; CNVM occurred in 55%. Eleven patients had greater than 20 year follow-up: all had macular atrophy with early radial drusen defining the extent of late macular atrophy. Large drusen tended to be replaced by atrophy over time. Six of these 11 patients with long term follow-up had disappearance of radial drusen (all 6 were in the severe phenotype category). Early in disease there was a perifoveal drusen-free zone with peripapillary sparing but at 20 years follow-up all patients had peripapillary changes. CNVM manifested in 7 of 11 (64%) patients by 20 year follow-up.

 
Conclusions
 

Extent of radial drusen early in the course of ADRD may correlate with location of atrophy up to 20 years later. Large central drusen tend to be replaced by geographic atrophy over time. Phenotypic variability is a prominent feature of the disease, but most patients develop atrophy and/or CNVM.

 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×